Abstract:Background Resuscitation with blood products is often required for pediatric cardiac surgery patients following cardiopulmonary bypass. However, data suggests that blood product transfusion is an independent predictor of adverse outcomes. Most studies have specifically found detrimental effects of overall transfusion of red blood cells in particular, but few have analyzed outcomes by the other specific blood product components. Aims The objective of this study is to analyze adverse outcomes associated with intraoperative transfusion of specific blood product components. Methods A retrospective review was performed on 643 pediatric patients who underwent cardiac surgery requiring cardiopulmonary bypass to evaluate the risk of selected adverse outcomes associated with intraoperative blood product transfusion. Adverse outcomes included thrombotic complications, stroke, acute kidney injury, prolonged mechanical ventilation, and death. Univariate logistic and linear regression analyses were performed to explore the association between various blood products and the occurrence of postoperative complications. Multiple logistic and linear regression analyses were performed adjusting for age, cyanotic status, STAT score, and cardiopulmonary bypass time. Results Unadjusted analysis using univariate logistic and linear regressions showed statistically significant associations of almost all blood components (per 10 ml/kg dose increments) with multiple postoperative complications, including mortality, thrombotic complications, stroke, and days of mechanical ventilation. After adjusting for patient age, cyanotic status, STAT score, and CPB time, multivariable logistic and linear regression analyses revealed no association between transfusion of blood products with acute kidney injury and stroke. Administration of RBCs was the only category significantly correlated with increased days of mechanical ventilation (0.5 days increase of mechanical ventilation per 10 ml/kg transfusion of RBCs). The only blood product to show complete lack of a statistically significant association with any of the studied outcomes was cryoprecipitate. Conclusions Transfusion of blood products following cardiopulmonary bypass is associated with postoperative adverse outcomes. Future studies aimed at strategies to reduce intraoperative bleeding and decrease the amount of blood products administered are warranted.

Duration of red-cell storage and complications after cardiac surgery.

Association Between Storage Time of Transfused Red Blood Cells and Infection after Clean-contaminated Surgery

Effects of red blood cell transfusion on patients undergoing cardiac surgery in Queensland - a retrospective cohort study

Effect of storage duration on outcome of patients receiving red blood cell in emergency department

Less transfusion is still more-red blood cell transfusion affects long-term mortality in cardiac surgery.

Storage Age of Transfused Red Blood Cells During Liver Transplantation and Its Intraoperative and Postoperative Effects

Red Blood Cell Transfusion and Pulmonary Complications: STS Adult Cardiac Surgery Database Analysis

Blood conservation strategies in cardiac valve replacement: A retrospective analysis of 1645 patients.

Transfusion of Older Red Blood Cells Increase the Risk of Postoperative Infectious Complications in Pediatric Scoliosis Surgery: a Propensity Score Matched Analysis

Effect of Age of Transfused Red Blood Cell Units on Clinical Outcomes in Critically Ill Patients

Impact of length of red blood cells transfusion on postoperative delirium in elderly patients undergoing hip fracture surgery: A cohort study.

Beneficial Effects of Prestorage Leukocyte-Reduced Red Blood Cell Transfusion on Postoperative Outcomes in Pediatric Patients Undergoing Cardiac Surgery

Duration of red blood cell storage and inflammatory marker generation

Retrospective Cohort Analysis of Associations Between Blood Transfusion and Postoperative Lung Injury after Cardiac Surgery

The pathophysiology and consequences of red blood cell storage

Intraoperative blood product transfusion in pediatric cardiac surgery patients: a retrospective review of adverse outcomes

Perioperative Transfusion Practices in Adults Having Non-Cardiac Surgery

The Impact of Blood Conservation on Outcomes in Cardiac Surgery: Is It Safe and Effective?

Morbidity And Mortality Risk Associated With Red Blood Cell And Blood-Component Transfusion In Isolated Coronary Artery Bypass Grafting

Effect of anaemia and cardiovascular disease on surgical mortality and morbidity

Number and Type of Blood Products Are Negatively Associated With Outcomes After Cardiac Surgery